Literature DB >> 11371332

Whole-body magnetic resonance imaging: techniques, clinical indications, and future applications.

R E Walker1, S J Eustace.   

Abstract

This article reviews developments in both pulse sequence design and gradient technology that facilitate rapid imaging of the whole body. It discusses its application in patients with bone marrow neoplasms, including metastases, lymphoma, and myeloma and emphasizes the value of whole-body magnetic resonance imaging in patients with known vertebral lesions to detect other bone lesions that are easier to biopsy. It outlines possible applications in well-defined clinical situations, including pregnancy and unknown primary tumor.

Entities:  

Mesh：

Year:  2001        PMID： 11371332     DOI： 10.1055/s-2001-12923

Source DB:  PubMed          Journal:  Semin Musculoskelet Radiol        ISSN： 1089-7860            Impact factor:   1.777


  18 in total

1.  Skeletal muscle metastasis from uterine leiomyosarcoma.

Authors:  J M O'Brien; D D Brennan; D H Taylor; D P Holloway; B Hurson; J C O'Keane; S J Eustace
Journal:  Skeletal Radiol       Date:  2004-05-04       Impact factor: 2.199

2.  [Possibilities of whole-body MRI for investigating musculoskeletal diseases].

Authors:  S Lenk; S Fischer; I Kötter; C D Claussen; H P Schlemmer
Journal:  Radiologe       Date:  2004-09       Impact factor: 0.635

3.  [Cost considerations for whole-body MRI and PET/CT as part of oncologic staging].

Authors:  C Plathow; M Walz; M P Lichy; P Aschoff; C Pfannenberg; H Bock; S M Eschmann; C D Claussen; H P Schlemmer
Journal:  Radiologe       Date:  2008-04       Impact factor: 0.635

4.  Whole-body MRI in the detection of bone marrow infiltration in patients with plasma cell neoplasms in comparison to the radiological skeletal survey.

Authors:  Nadir Ghanem; Christian Lohrmann; Monika Engelhardt; Gregor Pache; Markus Uhl; Ulrich Saueressig; Elmar Kotter; Mathias Langer
Journal:  Eur Radiol       Date:  2006-02-04       Impact factor: 5.315

Review 5.  The evolving role of MRI in oncohaematological disorders.

Authors:  O Tamburrini; M A Cova; D Console; P Martingano
Journal:  Radiol Med       Date:  2007-07-24       Impact factor: 3.469

6.  ¹⁸F-FDG PET/CT and 3.0-T whole-body MRI for the detection of distant metastases and second primary tumours in patients with untreated oropharyngeal/hypopharyngeal carcinoma: a comparative study.

Authors:  Sheng-Chieh Chan; Hung-Ming Wang; Tzu-Chen Yen; Chien-Yu Lin; Shy-Chyi Chin; Chun-Ta Liao; Yau-Yau Wai; Jiun-Jie Wang; Shu-Hang Ng
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-05-13       Impact factor: 9.236

7.  Detection of multifocal osteonecrosis in an adolescent with dermatomyositis using whole-body MRI.

Authors:  Tania C M Castro; Henrique Lederman; Maria Teresa A Terreri; Sue C Kaste; Maria Odete E Hilario
Journal:  Pediatr Radiol       Date:  2010-09

8.  Comparison of whole-body MRI with automatic moving table technique and bone scintigraphy for screening for bone metastases in patients with breast cancer.

Authors:  K Engelhard; H P Hollenbach; K Wohlfart; E von Imhoff; F A Fellner
Journal:  Eur Radiol       Date:  2003-07-05       Impact factor: 5.315

9.  [Whole-body MRI in comparison to skeletal scintigraphy for detection of skeletal metastases in patients with solid tumors].

Authors:  N Ghanem; T Kelly; C Altehoefer; J Winterer; O Schäfer; T A Bley; E Moser; M Langer
Journal:  Radiologe       Date:  2004-09       Impact factor: 0.635

Review 10.  [Whole-body tumor staging: MRI or FDG-PET/CT?].

Authors:  G Antoch; F M Vogt; A Bockisch; S G Ruehm
Journal:  Radiologe       Date:  2004-09       Impact factor: 0.635
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.